EssilorLuxottica is purchasing Optegra, a highly integrated ophthalmology platform operating in five key European markets: the United Kingdom, Czech Republic, Poland, Slovakia, and the Netherlands. Neither company disclosed the deal’s terms.

The acquisition represents a significant milestone in EssilorLuxottica’s medtech strategy, building on an offering that currently expands beyond frames and lenses to include artificial intelligence (AI)-powered technologies, wearables, medical instruments, and science-backed eye care solutions.

“With the acquisition of Optegra, we are stepping into a new frontier—one where comprehensive eyecare, advanced diagnostics, therapeutic interventions, and surgical treatments come together in one seamless platform,” commented EssilorLuxottica Chairman/CEO Francesco Milleri Deputy CEO Paul du Saillant. “We have the strategic assets to fuel this vision: an extensive distribution network with new clinical approaches, a smart eyewear offering with healthcare potential, and diagnostic capabilities that will be able to detect conditions ranging from neurodegenerative diseases to cardiovascular dysfunction. Optegra and its experienced doctors will bring new medical capabilities to our Group, enabling us to address patients’ needs with the most advanced vision care technologies and treatments in one trusted system that will anchor our medtech aspirations. Powered by our growing AI and big data capabilities, we will be able to broaden our impact and deliver the most personalized and seamless patient journey.” 

The Optegra group, under the Optegra, Lexum, and Iris brands, operates a network of more than 70 eye hospitals and diagnostic facilities in Europe, offering ophthalmic treatments and elective vision correction procedures supported by AI in pre- and post-op stages. These include sight-saving cataract surgery, age-related macular degeneration and glaucoma treatments, refractive lens replacement and laser eye surgery, serving both publicly reimbursed and private-pay patients. Since 2007, its surgeons and medical teams have established a strong foundation of clinical leadership and a reputation for quality care and outcomes.

“Optegra’s evolution under MidEuropa’s ownership reflects our approach to supporting high-quality European healthcare platforms with strong growth potential. We partnered with Peter Byloos and his leadership team to accelerate the company’s organic expansion and successfully entered two new markets, the Netherlands and Slovakia,” MidEuropa Managing Partner Robert Knorr stated. “We supported the opening of new clinics in the U.K. and completed eight strategic add-on acquisitions across five countries. We are proud to have contributed to Optegra’s digitalization, implementation of AI technologies, and broader mission to expand access to high-quality eye care. We would like to thank the management team and clinical staff for their dedication and ambition throughout this journey. We believe EssilorLuxottica is the ideal partner to lead Optegra into its next phase of growth and innovation, and we wish them every success as they build on the strong foundation we have helped create.”

The transaction is expected to close later this year, pending regulatory approvals and other customary closing conditions. 

“Joining forces with EssilorLuxottica marks a transformative chapter for Optegra. Their global leadership in vision care, combined with our clinical excellence and patient-centric approach, creates an innovative platform to redefine the paradigm of ophthalmic services. This partnership not only accelerates our growth potential but also enhances our ability to deliver advanced, digital and integrated eyecare solutions to all our patients. It also creates a significant opportunity for our clinical team, our staff and leadership to be part of a global and inspiring leader in vision care,” Optegra Eye Health Care CEO Dr. Peter Byloos stated.

Empowered by robust scientific research capabilities, distinctive expertise, a top-quality asset portfolio and an ongoing expansion into medtech, EssilorLuxottica drives cross-category innovation—from advanced medical instruments and solutions for eye health—through, among others, Essilor Instruments and Heidelberg Engineering – to smart eyewear that reimagines the eyes as a gateway to new possibilities.